脉炎消注射液的免疫学实验研究  

Immunological Study on Maiyanxiao Injection

作　　者：初洁秋[1] 韩莉 何维[2] 胡愉[2] 

机构地区：[1]哈尔滨医科大学第二临床医学院 [2]中国医学科学院基础医学研究所

出　　处：《中国实验方剂学杂志》1997年第6期27-30,共4页Chinese Journal of Experimental Traditional Medical Formulae

摘　　要：脉炎消注射液可在体外抑制ＰＨＡ诱导的健康人外周血淋巴细胞的增殖反应，对健康人外周血单个核细胞有直接的毒性杀伤作用，其中受作用的细胞主要为ＣＤ１９＋Ｂ细胞和ＣＤ４＋Ｔ细胞；脉炎消注射液还可抑制ｓＲＢＣ免疫小鼠ＩｇＭ型抗体生成细胞的产生及降低ｓＲＢＣ免疫小鼠的脾脏重量。Immunological mechanism of Maiyanxiao(MYX) injection,a traditional chinese medical formula was studied both in vitro and in vivo.Experimental MYX could inhibit PHA induced proliferation of peripheral blood lymphocytes from healthy donors and show a cytotoxicity towards CD19 + and CD4 + cells in vitro.MYX could suppress the production of antibody IgM producing cells and spleen weight in mice immunized with sheep red blood cells.In summary,MYX exert an immunosuppress activity.

关 键 词：脉炎消注射液 中药品 免疫学 实验研究 

分 类 号：R286[医药卫生—中药学]